Imaging biomarkers of oedema and fibrosis in a rat model of Drug-Induced-ILD

I. Mahmutovic Persson (Malmö, Sweden), A. öRbom (Lund, Sweden), P. öNnervik (Lund, Sweden), K. Wachenfeldt (Lund, Sweden), L. Olsson (Malmö, Sweden)

Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Mahmutovic Persson (Malmö, Sweden), A. öRbom (Lund, Sweden), P. öNnervik (Lund, Sweden), K. Wachenfeldt (Lund, Sweden), L. Olsson (Malmö, Sweden). Imaging biomarkers of oedema and fibrosis in a rat model of Drug-Induced-ILD. 2958

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biological- and imaging biomarkers of edema and fibrosis in a rat model of drug-induced interstitial lung disease (DIILD)
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019

Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging
Source: International Congress 2015 – New insights into IIPs
Year: 2015


Novel imaging biomarkers for assessment of lung fibrosis and inflammation
Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease
Year: 2021


Use of PET/CT to evaluate pulmonary inflammation and fibrosis in an animal model
Source: Eur Respir J 2006; 28: Suppl. 50, 606s
Year: 2006

Evolution of biomechanical changes in a murine model of bleomycin-induced lung fibrosis: inflammation versus fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 396s
Year: 2006

Molecular imaging of the progression of pulmonary fibrosis using animal models of disease
Source: Eur Respir J 2006; 28: Suppl. 50, 605s
Year: 2006

Specialized-proresolving mediators and trancriptomic signatures in bleomycin-induced lung fibrosis
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

Shear Wave imaging (SVI): A potential tool for analyzing early fibrotic changes in the subpleural space
Source: Annual Congress 2013 –The different modalities for current imaging and for future issues
Year: 2013

3he MRI and an animal model of interstitial lung disease
Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities
Year: 2009



Transient elastography detection of early liver fibrosis in idiopathic pulmonary fibrosis patients
Source: International Congress 2014 – ILDs 2
Year: 2014


Imaging cystic fibrosis lung disease with MRI
Source: Eur Respir Monogr 2015; 70: 188-206
Year: 2015


Nintedanib reduces bleomycin-induced lung inflammation and fibrosis in mice
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013


Changes in lung function in a rat model of mild emphysema
Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans
Year: 2009


Morphological characteristics and mechanism of a rat model of reexpansion pulmonary edema
Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels
Year: 2018

Preclinical models and imaging biomarkers of lung injury and disease
Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease
Year: 2021


Comparison of expression of napsin A and surfactant protein D in bleomycin-induced pulmonary fibrosis mouse model
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013

LSC Abstract – A human lung explant model of fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016

LATE-BREAKING ABSTRACT: Molecular imaging with CXCR4-gallium-68-pentixafor PET correlates with GAP index and treatment effects in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016

Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016


Tryptase+ mast cells associate with fibrotic regions in the lungs of idiopathic pulmonary fibrosis patients; a multiplex staining approach
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016